HUP0100580A3 - Formulations comprising dissolved paroxetine - Google Patents

Formulations comprising dissolved paroxetine

Info

Publication number: HUP0100580A3
Authority: HU; Hungary
Prior art keywords: formulations; paroxetine; dissolved; dissolved paroxetine
Prior art date: 1997-11-21

Application number

HU0100580A

Other languages

English (en)

Hungarian (hu)

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-21

Filing date

1998-11-18

Publication date

2002-05-28

1998-11-18 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2002-04-29 Publication of HUP0100580A2 publication Critical patent/HUP0100580A2/hu

2002-05-28 Publication of HUP0100580A3 publication Critical patent/HUP0100580A3/hu

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

HU0100580A 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine HUP0100580A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9724544.3A GB9724544D0 (en)	1997-11-21	1997-11-21	Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (fr)	1997-11-21	1998-11-18	Formulations contenant de la paroxetine dissoute

Publications (2)

Publication Number	Publication Date
HUP0100580A2 HUP0100580A2 (hu)	2002-04-29
HUP0100580A3 true HUP0100580A3 (en)	2002-05-28

Family

ID=10822374

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0100580A HUP0100580A3 (en)	1997-11-21	1998-11-18	Formulations comprising dissolved paroxetine

Country Status (24)

Country	Link
EP (1)	EP1033986A1 (fr)
JP (1)	JP2001523718A (fr)
KR (1)	KR20010032320A (fr)
CN (1)	CN1279608A (fr)
AP (1)	AP2000001821A0 (fr)
AR (1)	AR015485A1 (fr)
AU (1)	AU1168099A (fr)
BG (1)	BG104527A (fr)
BR (1)	BR9814220A (fr)
CO (1)	CO4970832A1 (fr)
DZ (1)	DZ2658A1 (fr)
EA (1)	EA200000552A1 (fr)
GB (1)	GB9724544D0 (fr)
HU (1)	HUP0100580A3 (fr)
IL (1)	IL136106A0 (fr)
MA (1)	MA24704A1 (fr)
NO (1)	NO20002590L (fr)
OA (1)	OA11385A (fr)
PE (1)	PE20000381A1 (fr)
PL (1)	PL340555A1 (fr)
SK (1)	SK7342000A3 (fr)
TR (1)	TR200001423T2 (fr)
WO (1)	WO1999026625A1 (fr)
ZA (1)	ZA9810637B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9810180D0 (en) *	1998-05-13	1998-07-08	Smithkline Beecham Plc	Novel formulation
ATE311883T1 (de) *	1999-03-12	2005-12-15	Aesica Pharmaceuticals Ltd	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
US6984632B1 (en)	1999-07-01	2006-01-10	Italfarmaco S.P.A.	Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
DE19930454A1 (de) *	1999-07-02	2001-01-04	Knoll Ag	Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en)	2001-02-16	2004-04-13	Andrx Corporation	Serotonin reuptake inhibitor formulations
ATE374602T1 (de) *	2001-12-21	2007-10-15	Supernus Pharmaceuticals Inc	Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) *	2002-02-15	2002-02-15	Ltp Lipid Technologies Provide	Oral farmaceutisk beredning
WO2006119779A2 (fr) *	2005-05-10	2006-11-16	Lifecycle Pharma A/S	Composition pharmaceutique comprenant un antagoniste de l'aldosterone
WO2011071194A1 (fr) *	2009-12-08	2011-06-16	주식회사 일화	Dispersions solides contenant du 20-o-β-d-glucopyranosyl-20(s)-protopanaxadiol
GB201020032D0 (en) *	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0818990A1 (fr) *	1995-04-03	1998-01-21	Abbott Laboratories	Melanges homogenes de medicaments fondant a basse temperature et d'additifs, destines a une liberation lente
NZ336587A (en) *	1997-01-15	2001-01-26	Smithkline Beecham P	Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran

1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
1998
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 EP EP98954631A patent/EP1033986A1/fr not_active Withdrawn
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/xx unknown
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/fr not_active Ceased
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Withdrawn
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/fr active
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
2000
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown

Also Published As

Publication number	Publication date
AP2000001821A0 (en)	2000-06-30
NO20002590D0 (no)	2000-05-19
PE20000381A1 (es)	2000-05-07
BG104527A (en)	2001-04-30
GB9724544D0 (en)	1998-01-21
TR200001423T2 (tr)	2000-10-23
DZ2658A1 (fr)	2003-03-22
OA11385A (en)	2004-01-27
EP1033986A1 (fr)	2000-09-13
AR015485A1 (es)	2001-05-02
PL340555A1 (en)	2001-02-12
KR20010032320A (ko)	2001-04-16
BR9814220A (pt)	2001-12-26
AU1168099A (en)	1999-06-15
WO1999026625A1 (fr)	1999-06-03
CO4970832A1 (es)	2000-11-07
NO20002590L (no)	2000-07-19
CN1279608A (zh)	2001-01-10
MA24704A1 (fr)	1999-07-01
JP2001523718A (ja)	2001-11-27
HUP0100580A2 (hu)	2002-04-29
IL136106A0 (en)	2001-05-20
SK7342000A3 (en)	2000-12-11
EA200000552A1 (ru)	2000-10-30
ZA9810637B (en)	2000-05-22

Publication	Publication Date	Title
GB9715751D0 (en)	1997-10-01	Formulations
SG79255A1 (en)	2001-03-20	Pharmaceutical formulations
PL343021A1 (en)	2001-07-30	Formulations
GB9713149D0 (en)	1997-08-27	Pharmaceutical formulations
EP1017379A4 (fr)	2007-01-24	Compositions therapeutiques
EP1030654A4 (fr)	2002-05-02	Preparation d'omeprazole
GB2323531B (en)	2001-02-21	Therapeutic formulations
IL136106A0 (en)	2001-05-20	Formulations comprising dissolved paroxetine
GB9726735D0 (en)	1998-02-18	Pharmaceutical compositions
GB2331703B (en)	2002-01-23	Disinfectant compositions
GB9806312D0 (en)	1998-05-20	Novel formulations
HU9700632D0 (en)	1997-05-28	Pharmaceutical compositions
GB9815002D0 (en)	1998-09-09	Formulations
IL139596A0 (en)	2002-02-10	Novel formulation containing paroxetine
GB9815001D0 (en)	1998-09-09	Formulations
GB2323042B (en)	1999-04-07	Nebulisers
IL139594A0 (en)	2002-02-10	Novel formulation containing paroxetine
HK1031821A (en)	2001-06-29	Formulations comprising dissolved paroxetine
GB9703099D0 (en)	1997-04-02	Formulations
GB9703101D0 (en)	1997-04-02	Formulations
GB9704521D0 (en)	1997-04-23	Formulations
GB9703100D0 (en)	1997-04-02	Formulations
GB9703607D0 (en)	1997-04-09	Pharmaceutical formulations
GB9816558D0 (en)	1998-09-30	Pharmaceutical formulations
GB9807556D0 (en)	1998-06-10	Pharmaceutical formulations